BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19228643)

  • 1. Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.
    Wagner PL; Kitabayashi N; Chen YT; Saqi A
    Am J Clin Pathol; 2009 Mar; 131(3):376-82. PubMed ID: 19228643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma.
    Sidiropoulos M; Hanna W; Raphael SJ; Ghorab Z
    Am J Clin Pathol; 2011 Jun; 135(6):831-8. PubMed ID: 21571955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
    Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
    Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
    Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
    Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
    Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
    Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small cell lung carcinoma with marked bronchial epithelial involvement.
    Rosen Y; Durie NM
    Int J Surg Pathol; 2011 Aug; 19(4):538-43. PubMed ID: 21632633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
    Buys TP; Aviel-Ronen S; Waddell TK; Lam WL; Tsao MS
    J Thorac Oncol; 2009 Feb; 4(2):227-39. PubMed ID: 19179901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
    Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
    Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation markers as an aid in the histological diagnosis of small-cell carcinoma of the lung: synopsis of intermediate filament protein and synaptophysin expression.
    Leube RE; Wiedenmann B; Franke WW
    Klin Wochenschr; 1988; 66 Suppl 11():80-6. PubMed ID: 2846953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors.
    Shestakova T; Zhuravel E; Bolgova L; Zaitsev S; Efanova O; Soldatkina M; Pogrebnoy P
    Exp Oncol; 2010 Dec; 32(4):273-6. PubMed ID: 21270758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow.
    Danbara M; Yoshida M; Kanoh Y; Jiang SX; Masuda N; Akahoshi T; Higashihara M
    Jpn J Clin Oncol; 2009 Nov; 39(11):771-5. PubMed ID: 19674995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact.
    Kontogianni K; Nicholson AG; Butcher D; Sheppard MN
    J Clin Pathol; 2005 Sep; 58(9):978-80. PubMed ID: 16126882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers.
    Kulshrestha R; Vijayan VK
    Indian J Chest Dis Allied Sci; 2009; 51(1):21-5. PubMed ID: 19317359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung tumours with neuroendocrine differentiation.
    Travis WD
    Eur J Cancer; 2009 Sep; 45 Suppl 1():251-66. PubMed ID: 19775623
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
    Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S
    Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping.
    Zaffaroni N; De Polo D; Villa R; Della Porta C; Collini P; Fabbri A; Pilotti S; Daidone MG
    J Pathol; 2003 Sep; 201(1):127-33. PubMed ID: 12950025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of microtubule-associated protein-2 in small cell lung carcinoma: an analysis of 240 biopsy cases].
    Zhou DM; Sun Y; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):321-4. PubMed ID: 24004589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for common clonal origin of multifocal lung cancers.
    Wang X; Wang M; MacLennan GT; Abdul-Karim FW; Eble JN; Jones TD; Olobatuyi F; Eisenberg R; Cummings OW; Zhang S; Lopez-Beltran A; Montironi R; Zheng S; Lin H; Davidson DD; Cheng L
    J Natl Cancer Inst; 2009 Apr; 101(8):560-70. PubMed ID: 19351924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.